Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Nutrition Education for the Health-care Provider Improves Patient Outcomes.

Baute V, Sampath-Kumar R, Nelson S, Basil B.

Glob Adv Health Med. 2018 Aug 24;7:2164956118795995. doi: 10.1177/2164956118795995. eCollection 2018.

2.

"Bipolar family": useful mnemonic to differentiate bipolar from unipolar depression.

Adetunji B, Mathews M, Basil B, Oyemade A.

Prim Care Companion J Clin Psychiatry. 2007;9(2):152-3. No abstract available.

3.

Psychosis Precipitated by Acetyl-l-Carnitine in a Patient With Bipolar Disorder.

Evcimen H, Mania I, Mathews M, Basil B.

Prim Care Companion J Clin Psychiatry. 2007;9(1):71-2. No abstract available.

4.

Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.

Evcimen H, Alici-Evcimen Y, Basil B, Mania I, Mathews M, Gorman JM.

J Psychiatr Pract. 2007 Mar;13(2):117-9. No abstract available.

PMID:
17414689
5.

Prescribing for buprenorphine in the treatment of opioid addiction.

Oyemade A, Adetunji B, Basil B, Mathews M.

Psychiatry (Edgmont). 2007 Mar;4(3):16. No abstract available.

6.

Mirtazapine-induced nightmares.

Mathews M, Basil B, Evcimen H, Adetunji B, Joseph S.

Prim Care Companion J Clin Psychiatry. 2006;8(5):311. No abstract available.

7.

Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.

Adetunji B, Basil B, Mathews M, Osinowo T.

Ann Pharmacother. 2007 Feb;41(2):359. Epub 2007 Jan 23. No abstract available.

PMID:
17244643
8.

Methylphenidate-induced neuroleptic malignant syndrome: a case report.

Basil B, Mathews M, Budur K.

Prim Care Companion J Clin Psychiatry. 2006;8(1):47. No abstract available.

9.

Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report.

Adetunji B, Basil B, Mathews M, Osinowo T.

J Clin Psychopharmacol. 2006 Aug;26(4):438. No abstract available.

PMID:
16855470
10.

A couvade syndrome variant?

Basil B, Mathews M.

Psychosomatics. 2006 Jul-Aug;47(4):363-4. No abstract available.

PMID:
16844901
11.

Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.

Adetunji B, Basil B, Mathews M, Williams A, Osinowo T.

J Clin Psychiatry. 2006 Mar;67(3):497; author reply 497-8. No abstract available.

PMID:
16649843
12.

Trial of risperidone in India--concerns.

Basil B, Adetunji B, Mathews M, Budur K.

Br J Psychiatry. 2006 May;188:489-90; author reply 490-1; discussion 491-2. No abstract available.

PMID:
16648540
13.

Assessment and treatment of Iraqi prisoners and civilians.

Mathews M, Basil B, Adetunji B.

Psychiatr Serv. 2006 Apr;57(4):580; author reply 581. No abstract available.

PMID:
16603767
14.

Pathological lying.

Adetunji B, Basil B, Budur K, Oladinni O.

J Am Acad Psychiatry Law. 2006;34(1):131-2; author reply 132-3. No abstract available.

PMID:
16585256
15.

The CATIE study.

Basil B, Mathews M, Adetunji B, Budur K.

Am J Psychiatry. 2006 Mar;163(3):555; author reply 555-6. No abstract available.

PMID:
16513895
16.

Better outcomes for schizophrenia in non-Western countries.

Mathews M, Basil B, Mathews M.

Psychiatr Serv. 2006 Jan;57(1):143-4. No abstract available.

PMID:
16399986
17.

Oxcarbazepine-induced thrombocytopenia.

Mahmud J, Mathews M, Verma S, Basil B.

Psychosomatics. 2006 Jan-Feb;47(1):73-4. No abstract available.

PMID:
16384812
18.

Human and animal health: strengthening the link: methodological concerns about animal facilitated therapy with dolphins.

Basil B, Mathews M.

BMJ. 2005 Dec 10;331(7529):1407; author reply 1407; discussion 1408. No abstract available.

19.

Is there evidence for effectiveness of acamprosate in maintaining abstinence in alcohol dependent patients?

Basil B, Thomas M, Chakrabarti I, George V, Mathews M, Adetunji B.

Psychiatry (Edgmont). 2005 Dec;2(12):49-52. No abstract available.

20.

India plans to audit clinical trials.

Basil B, Mathews M, Mahmud J, Adetunji B, Budur K.

BMJ. 2005 Nov 19;331(7526):1204-5. No abstract available.

21.

Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?

Basil B, Mahmud J, Mathews M, Rodriguez C, Adetunji B.

Psychiatry (Edgmont). 2005 Nov;2(11):64-9.

22.

Child psychopharmacology, effect sizes, and the big bang.

Mathews M, Adetunji B, Mathews J, Basil B, George V, Mathews M, Budur K, Abraham S.

Am J Psychiatry. 2005 Apr;162(4):818; author reply 818-9. No abstract available.

PMID:
15800177
23.

Antipsychotic-induced movement disorders: evaluation and treatment.

Mathews M, Gratz S, Adetunji B, George V, Mathews M, Basil B.

Psychiatry (Edgmont). 2005 Mar;2(3):36-41. No abstract available.

24.

Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol.

Basil B, Jordan R.

Eur J Pharmacol. 1982 May 7;80(1):47-56.

PMID:
6124437
25.

[The metabolism of acebutolol].

Basil B, Jordan R.

Nouv Presse Med. 1978 Oct 21;7(36):3258. French. No abstract available.

PMID:
733493
26.

A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols.

Basil B, Clark JR, Coffee EC, Jordon R, Loveless AH, Pain DL, Wooldridge KR.

J Med Chem. 1976 Mar;19(3):399-402.

PMID:
3647
27.

[Pharmacology of acebutolol in animals].

Basil B.

Nouv Presse Med. 1975 Dec 31;4(46 Suppl):3217-21. French.

PMID:
1219628
28.
29.

Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.

Basil B, Jordan R, Loveless AH, Maxwell DR.

Br J Pharmacol. 1973 Jun;48(2):198-211.

30.

Pharmacokinetics of M&B 17,803A in animals and man.

Basil B, Collins RF, Cuthbert MF.

Br J Pharmacol. 1973 Mar;47(3):620P. No abstract available.

31.

A new class of sympathetic beta-receptor blocking agents. 3,4-dihydro-3-hydroxy-1,5-benzoxazocine.

Basil B, Coffee EC, Gell DL, Maxwell DR, Sheffield DJ, Wooldridge KR.

J Med Chem. 1970 May;13(3):403-6. No abstract available.

PMID:
4394074
32.

A general purpose programmer for the laboratory.

Basil B.

Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;259(2):204. No abstract available.

PMID:
4232686
33.

THE ACTION OF SODIUM 4-HYDROXYBUTYRATE ON SPINAL REFLEXES.

BASIL B, BLAIR AM, HOLMES SW.

Br J Pharmacol Chemother. 1964 Apr;22:318-28.

34.

The influence of sex on the catabolism of griseofulvin.

BUSFIELD D, CHILD KJ, BASIL B, TOMICH EG.

J Pharm Pharmacol. 1960 Sep;12:539-43. No abstract available.

PMID:
13848149
35.

Stability of H. pertussis vaccine estimated by mouse-protection test.

UNGAR J, BASIL B.

Br Med J. 1957 Aug 31;2(5043):500-1. No abstract available.

36.

Routine experience of the mouse-protection assay of pertussis vaccine.

UNGAR J, BASIL B.

J Hyg (Lond). 1957 Mar;55(1):45-9. No abstract available.

37.

The pharmacological properties of benethamine penicillin.

BASIL B, IRELAND DM, THORN AG, TOMICH EG, SOMERS GF.

Antibiot Chemother (Northfield). 1955 Mar;5(3):152-61. No abstract available.

PMID:
24543404
38.

The properties of n-propyl 3:5-di-iodo-4-pyridone-N-acetate (propyliodone).

TOMICH EG, BASIL B, DAVIS B.

Br J Pharmacol Chemother. 1953 Jun;8(2):166-70. No abstract available.

39.

Measurement of thyroid activity by the mouse anoxia method.

BASIL B, SOMERS GF, WOOLLETT EA.

Br J Pharmacol Chemother. 1950 Jun;5(2):315-22. No abstract available.

40.

The pharmacology of phenadoxone or dl-6-morpholino-4:4-diphenyl-heptan-3-one hydrochloride.

BASIL B, EDGE ND, SOMERS GF.

Br J Pharmacol Chemother. 1950 Mar;5(1):125-41. No abstract available.

Supplemental Content

Support Center